Literature DB >> 7643913

A comparison of the effects of TMB-8 and nifedipine on pressor responses to alpha 1- and alpha 2-adrenoceptor agonists in pithed rats.

M A Aleixandre1, M Puerro, A Pintado.   

Abstract

TMB-8 has been characterized as an inhibitor of the release of Ca2+ from intracellular pools. We have studied the modification of the pressor responses to selective alpha 1-adrenoceptor agonists (methoxamine and phenylephrine), and to selective alpha 2-adrenoceptor agonists (B-HT 920 and B-HT 933) in pithed rats, produced by TMB-8. We have compared this modification with that produced by the calcium antagonist nifedipine. Nifedipine (100 micrograms/kg, 300 micrograms/kg, and 1000 micrograms/kg) inhibited in a dose-dependent manner the pressor responses to the alpha 1- and alpha 2-adrenoceptor agonists, the dose-response curves to the alpha 2-adrenoceptor agonists being shifted further to the right. TMB-8 at a dose of 3000 micrograms/kg did not modify the pressor effects of the alpha 1-adrenoceptor agonists, and neither did it reinforce the inhibition of such responses produced by nifedipine. By contrast, TMB-8 pretreatment (0.03 micrograms/kg, 0.3 micrograms/kg, 3 micrograms/kg, 30 micrograms/kg, 300 micrograms/kg and 3000 micrograms/kg) inhibited the responses to both alpha 2-adrenoceptor agonists, the inhibition being more pronounced with B-HT 920. A similar effect was obtained with 0.03 micrograms/kg TMB-8 and 0.3 microgram/kg TMB-8, particularly in the case of B-HT 920. It was stronger with higher doses, but similar for all doses over 3 micrograms/kg. The inhibition of the pressor responses mediated by the stimulation of alpha 2-adrenoceptors by TMB-8 was less in rats treated with the Ca2+ entry promoter BAY K 8644 (300 micrograms/kg), and could also be reduced by the continuous infusion of CaCl2 (0.25 microgram/min).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643913     DOI: 10.1007/bf00171041

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

Review 1.  Calcium handling in vasoconstriction to stimulation of alpha 1- and alpha 2-adrenoceptors.

Authors:  P B Timmermans; A T Chiu; M J Thoolen
Journal:  Can J Physiol Pharmacol       Date:  1987-08       Impact factor: 2.273

Review 2.  Alpha-adrenoceptor subclassification.

Authors:  K Starke
Journal:  Rev Physiol Biochem Pharmacol       Date:  1981       Impact factor: 5.545

Review 3.  alpha 2 adrenoceptors: classification, localization, mechanisms, and targets for drugs.

Authors:  P B Timmermans; P A van Zwieten
Journal:  J Med Chem       Date:  1982-12       Impact factor: 7.446

4.  Induction of Ca++ influx and intracellular Ca++ release in isolated rat aorta and mesenteric resistance vessels by norepinephrine activation of alpha-1 receptors.

Authors:  C Cauvin; S Malik
Journal:  J Pharmacol Exp Ther       Date:  1984-08       Impact factor: 4.030

5.  Possible relationship between receptor reserve and the differential antagonism of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses by calcium channel antagonists in the pithed rat.

Authors:  R R Ruffolo; E L Morgan; K Messick
Journal:  J Pharmacol Exp Ther       Date:  1984-09       Impact factor: 4.030

6.  Inhibitory effect of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) in vascular smooth muscle.

Authors:  H Ishihara; H Karaki
Journal:  Eur J Pharmacol       Date:  1991-05-17       Impact factor: 4.432

7.  Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.

Authors:  P A van Zwieten; J C van Meel; P B Timmermans
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

8.  Calcium dependency of vasoconstriction mediated by alpha 1- and alpha 2-adrenoceptors.

Authors:  P A van Zwieten; P B Timmermans; M J Thoolen; B Wilffert; A de Jonge
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

9.  Pharmacological evaluation of a new Ca2+ antagonist, 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8): studies in smooth muscles.

Authors:  M H Malagodi; C Y Chiou
Journal:  Eur J Pharmacol       Date:  1974-06       Impact factor: 4.432

10.  Effects of the irreversible alpha-adrenoceptor antagonists phenoxybenzamine and benextramine on the effectiveness of nifedipine in inhibiting alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in pithed rats.

Authors:  P B Timmermans; M J Thoolen; M J Mathy; B Wilffert; A de Jonge; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.